WELL Health Technologies Corp.
WHTCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $919,688 | $776,054 | $569,136 | $302,324 |
| % Growth | 18.5% | 36.4% | 88.3% | – |
| Cost of Goods Sold | $556,677 | $403,787 | $265,845 | $148,629 |
| Gross Profit | $363,011 | $372,267 | $303,291 | $153,695 |
| % Margin | 39.5% | 48% | 53.3% | 50.8% |
| R&D Expenses | $0 | $3,461 | $3,151 | $0 |
| G&A Expenses | $236,872 | $212,689 | $176,411 | $107,747 |
| SG&A Expenses | $321,470 | $276,978 | $224,106 | $123,522 |
| Sales & Mktg Exp. | $84,598 | $64,289 | $47,695 | $15,775 |
| Other Operating Expenses | $71,736 | $63,259 | -$2,003 | $1,549 |
| Operating Expenses | $393,206 | $337,110 | $279,309 | $161,738 |
| Operating Income | -$30,195 | $35,157 | $23,311 | -$12,792 |
| % Margin | -3.3% | 4.5% | 4.1% | -4.2% |
| Other Income/Exp. Net | $39,187 | -$15,660 | -$5,786 | -$11,990 |
| Pre-Tax Income | $8,992 | $19,497 | $17,921 | -$24,765 |
| Tax Expense | -$20,104 | $2,860 | -$1,150 | $5,921 |
| Net Income | $32,609 | $82 | $1,369 | -$43,787 |
| % Margin | 3.5% | 0% | 0.2% | -14.5% |
| EPS | 0.13 | 0 | 0.006 | -0.23 |
| % Growth | 43,233.3% | -95.2% | 102.7% | – |
| EPS Diluted | 0.13 | 0 | 0.006 | -0.23 |
| Weighted Avg Shares Out | 246,764 | 236,994 | 220,691 | 190,900 |
| Weighted Avg Shares Out Dil | 254,652 | 236,543 | 220,691 | 190,900 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,272 | $1,283 | $649 | $555 |
| Interest Expense | $35,505 | $32,840 | $22,340 | $7,548 |
| Depreciation & Amortization | $72,306 | $50,217 | $55,203 | $38,710 |
| EBITDA | $116,803 | $91,326 | $95,068 | $32,007 |
| % Margin | 12.7% | 11.8% | 16.7% | 10.6% |